As shown in Figure 2, IL-24 inhibits the growth of different breast cancer cells lines containing wild-type TP53 (MCF-7), mutant TP53 (MDA-MB-231 and T47D), or null TP53 (MDA-MB-157). Here, TP53 is linked to breast carcinoma.